CVX vs RAPP · P/E 17, rev $118.66B vs rev $20.0M
Chevron Corp (CVX) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported RAPP revenue for 2026-06-30 was $20.0M. Net income was -$76.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the CVX and RAPP stock pages for the full models.
Not investment advice.